MTLS
MATERIALISE SP ADS (MTLS)
NASDAQ
$6.42-$0.07 (-1.08%)
Price as of Jun 23, 2026 4:34 PM EDT
  • $377.2M
    Market Cap
  • 20.19%
    1-Year Change
  • Software - Application
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 57
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

TCT Asia 2026 Opens Registration: Welcoming the Global Additive Manufacturing Community to Shanghai

TCT Asia 2026, the leading additive manufacturing event in Asia-Pacific, has opened free visitor registration for its March 17-19 event in Shanghai. The event will span 55,000+ m² across two halls featuring over 550 exhibitors, including global leaders and Chinese innovators in metal and polymer 3D printing technologies, alongside a revamped conference format with expert sessions and professional certification courses.

01/22/2026, 10:00 AM • GlobeNewswire

Surgical Simulation Market Research Report 2025-2030

The global surgical simulation market is projected to grow at a 15.65% CAGR from 2024 to 2030, reaching $1.14 billion, driven by technological advancements in VR, AI, and haptic feedback that enhance medical training and reduce surgical errors.

11/11/2025, 4:37 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$6.47
$6.71
$6.49
1-Year Range
$4.80
$6.89
$6.49
Latest Close$6.49
Change
-$0.22 (-3.39%)
Volume95,224
Market Cap$377.2M
Shares Outstanding58.1M
P/E (TTM)49.92
Diluted EPS (TTM)$0.13
Enterprise Value$253.6M

Information as of 06/22/2026

Company Profile

$377.2M
Market Cap
$7.7M
Net Income
Sector: Technology
Industry: Software - Application
Technologielaan 15, Leuven, Belgium, 3001
32 1 639 66 11

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Key Executives

  • Koen Berges
  • Valérie Nerinckx
  • Carla Van Steenbergen
  • Brigitte de Vet-Veithen
  • Wilfried Vancraen

Current Ownership Distribution

  • Institutions230.1M (79.58%)
  • Mutual Funds59.1M (20.42%)
  • Insiders0 (0.00%)
  • Other0 (0.00%)